Drugs used in benign prostatic hypertrophy.
Treatment and control of benign prostatic hyperplasia (BPH) in patients with an enlarged prostate to:
- size reduction (regression) of enlarged prostate to improve urine flow and reduce symptoms associated with benign prostatic hyperplasia;
- reduce the risk of acute urinary retention and the need for surgical intervention, including prostate and transuretrorezektsii prostatectomy.
Hypersensitivity to finasteride or to any component of the drug. Prostan is not indicated for use in women and children.
Round-shaped tablets, coated tablets, reddish-pink in color, the upper and lower surfaces are convex. At the break when viewed under a microscope can see a core surrounded by one continuous layer.
Keep in original package at temperature not exceeding 30 оС.
Keep out of reach of children